Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update
Announced positive data from the Phase 1 clinical trial of ELVN-001 in CML, reporting a cumulative MMR rate of 47%...
Morning Movers
Drilling Tools International Corp. Reports 2025 Second Quarter Results
Company maintains full year 2025 outlook HOUSTON, Aug. 13, 2025 /PRNewswire/ -- Drilling Tools International Corp. (NASDAQ: DTI) ("DTI" or...
MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability.Operating Expenses Cut 70% as Turnaround Gains Traction...
Expion360 Reports Second Quarter 2025 Financial and Operational Results
Q2 2025 Sales Growth of 134% to $3.0 Million Fueled by Strong Demand for New Products and Technologies Records Two...
Longeveron® Announces Second Quarter 2025 Financial Results and Provides Business Update
Full enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS,...
Aqua Metals Advances Commercialization of AquaRefining™ Technology with Industry-Leading Lithium Quality and Strategic Progress During Second Quarter of 2025
RENO, Nev., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), a pioneer in...
Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial Results
PALO ALTO, Calif., Aug. 13, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial...
Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update
Australian Cancer Trial Advances with First Cohort Complete, Amended Protocol, and Promising Preclinical Data Published; Operating Expenses Cut by 32%...
IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing
TORONTO and GLIL YAM, Israel, Aug. 13, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC), a...
SurgePays Accelerates Growth Across All Business Verticals; Reports Q2 2025 Results and Issues Revenue Guidance of $75M to $90M in 2025 and $225M to $240M in 2026
BARTLETT, Tenn., Aug. 13, 2025 /PRNewswire/ -- SurgePays, Inc. (Nasdaq: SURG) ("SurgePays" or the "Company"), a wireless and point-of-sale technology...
Stonegate Capital Partners Updates Coverage On Surf Air Mobility Inc. (SRFM) 2025 Q2
Dallas, Texas--(Newsfile Corp. - August 13, 2025) - Surf Air Mobility Inc. (NYSE: SRFM): Stonegate Capital Partners updates their coverage...
Spire Global Announces Preliminary Second Quarter 2025 Revenue and Provides Business Update
VIENNA, Va.--(BUSINESS WIRE)--Spire Global, Inc. (NYSE: SPIR) (“Spire” or “the Company”), a global provider of space-based data, analytics and space...
Fossil Group, Inc. Reports Second Quarter 2025 Financial Results
Delivers positive operating income Second quarter 2025 worldwide net sales totaled $220 million Gross margin expanded 490 basis points to...
Fossil Group, Inc. Announces ABL Refinancing and Transaction Support Agreement for Debt Exchange
RICHARDSON, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (NASDAQ: FOSL) (“Fossil” or the “Company”) today announced that...
ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025
ProPhase Delivers Significant Operational and Financial Improvements, Advances Multiple Non-Dilutive Liquidity Initiatives, and Targets Transformational Growth Catalysts Company granted key...
dLocal Reports 2025 Second Quarter Financial Results
TPV at record high of US$9.2 billion, growing more than 50% YoY for the third consecutive quarter.Brazil and Mexico posted...
dLocal announces appointment of Chief Financial Officer
MONTEVIDEO, Uruguay, Aug. 13, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”, “we”, “us”, and “our”) (NASDAQ:DLO), a technology - first...
BeyondSpring Reports Second‑Quarter 2025 Financial Results and Provides Corporate Update: Accelerates Momentum with Promising Clinical Advances and Strategic Leadership Appointment
ASCO 2025 presentation: First-in-class agent Plinabulin drives immune re-sensitization in NSCLC patients progressed to PD-1/L1 therapiesMed (Cell Press) Publication with MD...
Interlink Electronics Reports Strong Second Quarter 2025 Results
Q2 2025 Revenue up 18%, Driving Solid Gross Margins and ProfitabilityBeginning Production on Integrated Sensing Solution for Division of Top...
Interlink Electronics Reports Strong Second Quarter 2025 Results
Q2 2025 Revenue up 18%, Driving Solid Gross Margins and ProfitabilityBeginning Production on Integrated Sensing Solution for Division of Top...
Nuvalent to Present Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025 Presidential Symposium
CAMBRIDGE, Mass., Aug. 13, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
Topline results from the OV329 Phase 1 safety, tolerability and biomarker study remain on track for a readout in Q3...
European Wax Center, Inc. Reports Second Quarter Fiscal Year 2025 Results
Second Quarter Fiscal 2025 versus 2024 1,059 total centers in 44 states was flatSystem-wide sales of $257.6 million decreased 1.0%Total...
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Therapeutics, Inc., a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets...
WallachBeth Capital Announces Pricing of bioAffinity Technologies Private Placement and Concurrent Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds
JERSEY CITY, N.J., Aug. 13, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution...
ImmunityBio Reports Complete Responses in Non-Hodgkin Waldenstrom Lymphoma Patients with Chemotherapy-Free, First-In-Class CD19 CAR-NK Immunotherapy
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio (NASDAQ: IBRX), a leading immunotherapy company, announced today early findings from its QUILT-106 Phase I trial,...
New Blackbaud Institute Report Reveals Key Drivers of Effective Risk Management for Social Impact Organizations
Organizations That Prioritize Technology and Talent Investments Report Significantly Lower Concerns about Managing Risk CHARLESTON, S.C., Aug. 13, 2025 /PRNewswire/...
MCAP Inc. Reports Second Quarter 2025 EPS of $0.28 Per Share
ORLANDO, Fla., Aug. 13, 2025 /PRNewswire/ -- MCAP Inc. (OTC: MCAP), a financial technology and securities market making company, today...
VerifyMe Reports Second Quarter 2025 Financial Results
Cash of $6.1 million as of June 30, 2025, with cash provided by operations of $0.7 million in Q2 2025,...
Thumzup Media Corporation Expands Strategic Relationship with Coinbase to Accelerate Cryptocurrency Accumulation
$50 Million Raise at $10/Share Positions Thumzup for Aggressive Crypto Portfolio Growth and Mining BuildoutThe Company is Authorized to Allocate...
VINCI COMPASS TO HOST INVESTOR DAY ON OCTOBER 07, 2025
RIO DE JANEIRO, Aug. 13, 2025 /PRNewswire/ -- Vinci Compass Investments Ltd. (NASDAQ: VINP) ("Vinci Compass," "the Company," "we," "us,"...
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT – Advancing Breakthrough Therapy for Chronic Lower Back Pain
PHOENIX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company focused on...
NWTN Inc. Announces Results of Its Extraordinary General Meeting of Shareholders on August 12, 2025
DUBAI, UAE, Aug. 13, 2025 /PRNewswire/ -- NWTN Inc. (Nasdaq: NWTN) (the "Company"), a Nasdaq-listed company headquartered in the UAE,...
Momentus Secures NASA Contract to Study the Launch of Robotic Technologies for Future Space Exploration
SAN JOSE, Calif.--(BUSINESS WIRE)--Momentus Inc. (NASDAQ: MNTS), a U.S. commercial space company offering satellites, satellite components, and in-space transportation and...
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results
Processed 2,756 EsoGuard® tests and recognized 2Q25 revenue of $1.2 million, ending quarter with over $30 million in proforma cash...
Local Bounti Appoints Dane Almassy as Chief Commercial Officer
HAMILTON, Mont., Aug. 13, 2025 /PRNewswire/ -- Local Bounti Corporation (NYSE: LOCL) ("Local Bounti" or the "Company"), a breakthrough U.S....
Local Bounti Announces Second Quarter 2025 Financial Results
Reports 28% Year-Over-Year Revenue Growth Driven by Expanded Facility Operations and Strengthened Retail Relationships Achieved $7 Million in Annualized Expense...
X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people...
Unitronix Corp. Adopts $0.50 Milestone-Based Stock Option Program for CEO, Advisors, and Insiders
Performance-based equity program align leadership rewards with treasury growth and market capitalization milestones MARLTON, N.J., Aug. 13, 2025 /PRNewswire/ -- Unitronix...
Smartkem to Deliver Feature Presentations at the 25th International Meeting on Information Display (IMID) in Busan, Korea
Smartkem's Head of Technology Transfer Steven Tsai will be delivering a talk on behalf of the Dean of Hon Hai...